Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation
Links shared publicly online about this topic.
- 795total visits
Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation
View full resource at medicalnewstoday.com
Tags: Drug, Clinical Trial, FDA
Most Recently Shared on October 17, 2010 at 12:05 pm By:
Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation http://mnt.to/3LjV
Also Shared By:
Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation - QualityPoint Technologies
qualitypointtech.net — “Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating the Medtronic CoreValve System for transcatheter aortic valve implantation (TAVI). The CoreValve System is designed to provide a minimally invasive, non-surgical treatment option for patients with symptomatic, severe aortic stenosis who are at high risk, or are ineligible, for op” View full resource at qualitypointtech.net
Most Recently Shared on October 17, 2010 at 4:33 pm By:
Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation: ... http://bit.ly/bea8CT
Advertisement
MNT Cardiovascular
@mnt_cardiovasc
Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation http://mnt.to/3LjV
1 year ago...